Literature DB >> 3738953

Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community.

Y Kiyohara, K Ueda, Y Hasuo, I Fujii, T Yanai, J Wada, H Kawano, T Shikata, T Omae, M Fujishima.   

Abstract

To elucidate the relation of hematocrit (Hct) to the incidence of cerebral infarction, a prospective follow-up study of 16 years (1965-81) was performed in a general population sample of 1220 Hisayama residents aged 44 and over, of both sexes. Most of the subjects who died during the follow-up period were autopsied, the rate being 89.0%. Hct decreased with advancing age in men, but not in women. The average value for Hct was significantly lower in women than in men. According to the mean value +/- 1 SD of Hct, the subjects were grouped into 3, in each sex as follows: low (less than 35%), normal (35-45%) and high (greater than or equal to 45%) for men, and, low (less than 30%), normal (30-40%) and high (greater than or equal to 40%) for women. During the follow-up period, cerebral infarction occurred in 117 patients. The cumulative incidence of cerebral infarction in the low Hct group for men was the lowest, even after adjustments for age and blood pressure. Conversely, the incidence in the low Hct group of women was significantly higher than that in the normal Hct group and was consistently increased with time during 2-5 years of the follow-up. After the 6th year or later, however, the incidence was gradually but significantly increased in the high Hct group, compared with the normal Hct group. Since Hct levels were related with other variables such as serum total cholesterol, serum total protein, Quetelet index and prevalence of hypertension in both sexes, heavy alcohol consumption in men, and glucose intolerance in women, such variables were taken into account using Cox's proportional hazards regression model.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3738953     DOI: 10.1161/01.str.17.4.687

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

Review 1.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

2.  A U-shaped relationship between haematocrit and mortality in a large prospective cohort study.

Authors:  Paolo Boffetta; Farhad Islami; Rajesh Vedanthan; Akram Pourshams; Farin Kamangar; Hooman Khademi; Arash Etemadi; Rasool Salahi; Shahryar Semnani; Ashkan Emadi; Christian C Abnet; Paul Brennan; Paul D Pharoah; Sanford M Dawsey; Reza Malekzadeh
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

Review 3.  Current management of ischaemic stroke.

Authors:  R S Marshall; J P Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

4.  Response by Gutiérrez et al to Letter Regarding Article, "Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults".

Authors:  Orlando M Gutiérrez; Bhupesh Panwar; Suzanne E Judd
Journal:  Stroke       Date:  2016-10-06       Impact factor: 7.914

Review 5.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

6.  Meta-analysis of relation between cigarette smoking and stroke.

Authors:  R Shinton; G Beevers
Journal:  BMJ       Date:  1989-03-25

7.  Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.

Authors:  Bhupesh Panwar; Suzanne E Judd; David G Warnock; William M McClellan; John N Booth; Paul Muntner; Orlando M Gutiérrez
Journal:  Stroke       Date:  2016-07-05       Impact factor: 7.914

Review 8.  Haemodilution for acute ischaemic stroke.

Authors:  Timothy S Chang; Matthew B Jensen
Journal:  Cochrane Database Syst Rev       Date:  2014-08-27

9.  Hematocrit and the incidence of stroke: a prospective, population-based cohort study.

Authors:  Renling Yang; Anxin Wang; Li Ma; Zhaoping Su; Shuohua Chen; Yilong Wang; Shouling Wu; Chen Wang
Journal:  Ther Clin Risk Manag       Date:  2018-10-23       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.